The NHS has unveiled an innovative tech initiative to help people who are most at risk of developing type 2 diabetes. According to Pharma File on Wednesday, the news coincided with World Diabetes Day, which was on Tuesday.
The novel scheme will see more than 5,000 patients in eight areas of England enrolled. They will each be tested and monitored using apps that track physical activity and other health data.
Five companies will provide their devices for the trial; these include wristbands that provide feedback to mobile devices and a six-week mobile and desktop digital programme that measures sleep and helps with healthy eating. Researchers hope to establish whether digital interventions like these can offer a cost effective means of preventing high-risk patients from developing type 2 diabetes.
Duncan Selbie, chief executive at Public Health England, commented: "This breaks new ground to help those at risk of type 2 diabetes quite literally take their health into their own hands. Many of us use on-the-go digital technology every day and this is a logical next step in diabetes prevention."
Simon Stevens, the CEO of NHS England, added: "So much else in our lives is now about online social connection and support, and that now needs to be true too for the modern NHS. This is the latest example of how the NHS is getting practical and serious about supporting people to stay healthy".
Airiver medical receives FDA approval for central airway stenosis trial
Talphera reaches enrollment milestone in NEPHRO CRRT pivotal trial
QT Imaging signs exclusive USD33m distribution deal with Gulf Medical in Saudi Arabia
Novocure submits FDA PMA for Tumor Treating Fields therapy in pancreatic cancer
Covalon Technologies secures DTC eligibility to expand US investor access
Navamedic ASA secures final approvals for Flexilev in OraFID across Nordic markets
Oncopeptides partners with SD Pharma to expand Pepaxti access in Spain
Aptar launches bio-based nasal spray pump with Haleon's Otrivin brand
PharmaJet signs MOU with Egyptian UPA and EVA Pharma to introduce needle-free vaccine delivery
Alcon to acquire LumiThera and its FDA-authorised photobiomodulation device for dry AMD treatment
Predictmedix AI launches mobile diabetes screening platform in India
Navamedic's medical device OraFID approved as primary package for a pharmaceutical product
Speranza Therapeutics partners with Sunshine Labs for harm reduction solutions